Specialty Pharmacy

ElastPQ technique can better detect liver fibrosis in patients with hepatitis C.

A new grant will fund a 5-year study on how mobile technology can assist minority patients with diabetes treatment adherence.

Adjuvant treatment with recombinant, human monoclonal antibody extended overall survival in patients with melanoma in a recent trial.

A health and exercise program may improve quality-of-life in patients recovering from bowel cancer.

Top news of the day from across the health care landscape.

Large proportion of adolescents who are HIV-positive are unaware of their infection.

Zitter Health Insights and Specialty Pharmacy Times partner to recognize the top performing specialty pharmacies based on patient satisfaction.

Patients achieve results when complex therapy is expertly guided by a specialty pharmacy.

LEE011 plus letrozole may prove to be effective first-line breast cancer therapy.

Stool transplantation in patients who have an infection of the bowel with recurrent C. difficile shows promise.

HIV-infected patients may have worse outcomes in ocular syphilis than those without the virus.

Researchers unveil the molecular workings of MS drug Tecfidera using new technology.

Top news of the day from across the health care landscape.

Researchers discover which type of gut bacteria may influence the effectiveness of chemotherapy.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.

Top news of the week in oncology, and cancer drug development.

The loss of interleukin-33 allows tumors to hide from the immune system.

Alecensa found to increase progression-free survival in ALK-positive non-small cell lung cancer compared with crizotinib.

Top news of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The rise in indoor temperatures worsened respiratory symptom scores and increased the use of recuse inhalers, a new study found.

Researchers have uncovered the mechanisms of resistance to Yervoy in patients with skin cancer.

Continuous glucose monitoring system provides health care professionals with clear, visual snapshots of glucose levels.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs.

Study quantifies global body composition changes in patients with hepatitis C.

Natural killer cells ‘trained’ to more effectively attack cancer cells in patients with AML.

Top news of the day from across the health care landscape.

With no current treatments for patients with aggressive MS, new study findings provide hope.

The combined use of radiation therapy and a neutrophil stimulant can increase anti-tumor immunity.

New insights into a gene with anti-cancer activity may grow options for cancer treatment.